Anzeige
Mehr »
Donnerstag, 24.07.2025 - Börsentäglich über 12.000 News
Neubewertung voraus? Wird die Aktivierung der EU-Lizenz zum Kurs-Katalysator für die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
143 Leser
Artikel bewerten:
(0)

Black Book Research: Black Book Survey Highlights Growing Divide Over AI Regulation in U.S. Healthcare

Providers, Vendors, and Consumers Voice Conflicting Views on Patient Safety, Transparency, and Oversight in Expanding AI Ecosystem

WASHINGTON, DC / ACCESS Newswire / July 23, 2025 / Black Book Research today released findings from a national flash survey revealing significant differences in opinion regarding the regulation of artificial intelligence (AI) in healthcare among providers, technology vendors, and healthcare consumers. The survey illustrates a growing demand for oversight from providers and patients, while AI developers express concerns about potential impacts on innovation and market dynamics.

The study reflects a 360-degree perspective on AI adoption and risk management by capturing responses from: 90 AI professionals representing hospitals, health systems, and health plans; 24 senior executives from leading healthcare AI vendor organizations; and 300 U.S. healthcare consumers.

"The healthcare sector is embracing artificial intelligence at an accelerating pace, but regulatory structures have not evolved proportionately," said Doug Brown, President of Black Book Research. "This flash poll underscores the need for multi-stakeholder collaboration to ensure responsible innovation while addressing patient safety, ethical use, and trust."

Key Findings

Patient Safety and AI Validation

73% of provider and payer professionals surveyed indicated that current AI tools are being implemented in care environments without adequate clinical validation. Only 16% of vendor executives shared the same concern. Among consumers, 89% support mandatory government testing and approval of AI technologies used in diagnosis, risk scoring, or care planning.

Transparency and Informed Consent

80% of providers reported that patients are generally not informed when AI is involved in decision-making or treatment selection. Only 8% of vendors support regulatory requirements to notify patients about AI-driven interventions. 92% of consumers expressed a desire to be notified when AI plays a role in their care, and 97% stated they would be uncomfortable if clinical decisions were made without human review.

Legal Accountability

85% of healthcare professionals cited a lack of clarity around liability when AI tools are involved in patient harm or adverse events. 96% of vendor leaders believe responsibility should fall on the healthcare organization using the tool. 77% of consumers surveyed agreed that providers should be held accountable for AI-related errors, regardless of third-party software involvement.

Bias and Health Equity

89% of providers believe AI systems risk perpetuating racial, gender, and or socioeconomic bias. Only 14% of vendor executives acknowledged bias as a systemic concern. Among consumers identifying as members of underserved populations, 96% reported concern about algorithmic bias, and 88% support legislation requiring mandatory bias testing before clinical deployment.

Regulatory Gaps in the U.S. Healthcare Ecosystem

The survey also identified broad concern about the lack of regulatory cohesion across federal and state levels:

40% of providers view current federal oversight as inadequate to ensure safe and ethical AI deployment in clinical environments. 93% indicated that their organizations operate in states with no existing healthcare AI regulatory guidance. Only 7% of vendors support expanded federal regulation. 92% of healthcare consumers indicated support for the establishment of a national oversight body dedicated to AI in healthcare.

Cybersecurity and Data Governance

79% of providers surveyed reported concerns that many healthcare AI tools are introduced without sufficient cybersecurity protections or transparent data governance. Only 13% of vendor executives acknowledged the need for additional cybersecurity layers beyond their current models. 98% of consumers expressed concern regarding the collection and use of personal health data by AI systems, particularly those involving third-party analytics platforms.

__________

Global Regulatory Landscape: A Comparative Perspective

Black Book Research notes that regulatory challenges in the U.S. are mirrored in many international healthcare markets. While AI in medicine is rapidly advancing globally, the development of ethical and safety frameworks remains inconsistent.

China: China continues to lead in AI deployment across healthcare systems, yet there are no national requirements for algorithm transparency or explainability. AI systems are often deployed in public hospitals without independent validation and Patient data privacy regulations are limited or poorly enforced, especially in large-scale government-sponsored initiatives.

European Union: The upcoming EU Artificial Intelligence Act introduces risk-based classifications for AI tools, with healthcare algorithms largely categorized as high-risk. The legislation will require: Mandatory risk and performance documentation; Bias mitigation testing; and Ongoing algorithmic transparency for regulated AI applications.

Canada and Australia: rely on broad medical device laws with healthcare AI-specific regulations still under development.

Latin America and Africa: are seeing increasing adoption of AI in public health and remote care but lack uniform regulatory frameworks.

"We're seeing a misalignment between the creators of healthcare AI, the clinicians expected to use it responsibly, and the patients whose lives are impacted by it," said Brown. "As federal policy trends toward lighter-touch AI regulation across industries, it's increasingly clear that healthcare cannot afford to be treated like every other sector. The stakes are too high, and the expectations from the front lines and the public are too urgent to ignore."

About Black Book Research

Black Book Research is an independent healthcare market research and public opinion firm, recognized for its commitment to unbiased insights and data integrity. Over the past 15 years, Black Book has gathered more than 3 million validated viewpoints from healthcare professionals, including physicians, nurses, administrators, and IT leaders. The firm specializes in flash surveys, longitudinal studies, and deep-dive benchmarking across health technology, operations, and clinical transformation. Using a combination of expert panels, online surveying, and modern data collection tools, Black Book delivers real-time, actionable insights to stakeholders across the healthcare industry. Many of its comprehensive research reports are provided gratis to healthcare providers, payers, and policymakers to eliminate vendor influence and promote transparency in technology decision-making and performance evaluation.

Reach us at www.blackbookmarketresearch.com

Contact Information

Press Office
research@blackbookmarketresearch.com
8008637590

.

SOURCE: Black Book Research



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/black-book-survey-highlights-growing-divide-over-ai-regulation-in-u.s-1051891

© 2025 ACCESS Newswire
Hensoldt, Renk & Rheinmetall teuer
Rheinmetall, Renk und Hensoldt haben den Rüstungsboom der letzten Jahre dominiert, doch inzwischen sind diese Titel fundamental heillos überbewertet. KGVs jenseits der 60, KUVs über 4, und das in einem politisch fragilen Umfeld mit wackelnder Haushaltsdisziplin. Für späteinsteigende Anleger kann das teuer werden.

Doch es gibt Alternativen, die bislang unter dem Radar fliegen; solide bewertet, operativ stark und mit Nachholpotenzial.

In unserem kostenlosen Report zeigen wir dir, welche 3 Rüstungsunternehmen noch Potenzial haben und wie du von der zweiten Welle der Zeitenwende profitieren kannst, ohne sich an überhitzten Highflyer zu verbrennen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders vom weltweiten Aufrüsten profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.